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Schistosoma mansoni masks its surface with adsorbed host proteins including erythrocyte antigens, immu-
noglobulins, major histocompatibility complex class I, and b2-microglobulin (b2m), presumably as a means of
avoiding host immune responses. How this is accomplished has not been explained. To identify surface
receptors for host proteins, we biotinylated the tegument of live S. mansoni adults and mechanically trans-
formed schistosomula and then removed the parasite surface with detergent. Incubation of biotinylated
schistosome surface extracts with human immunoglobulin G (IgG) Fc-Sepharose resulted in purification of a
97-kDa protein that was subsequently identified as paramyosin (Pmy), using antiserum specific for recombi-
nant Pmy. Fc also bound recombinant S. mansoni Pmy and native S. japonicum Pmy. Antiserum to Pmy
decreased the binding of Pmy to Fc-Sepharose, and no proteins bound after removal of Pmy from extracts.
Fluoresceinated human Fc bound to the surface, vestigial penetration glands, and nascent oral cavity of
mechanically transformed schistosomula, and rabbit anti-Pmy Fab fragments ablated the binding of Fc to the
schistosome surface. Pmy coprecipitated with host IgG from parasite surface extracts, indicating that com-
plexes formed on the parasite surface as well as in vitro. Binding of Pmy to Fc was not inhibited by soluble
protein A, suggesting that Pmy does not bind to the region between the CH2 and CH3 domains used by many
other Fc-binding proteins. b2m did not bind to the schistosome Fc receptor (Pmy), a finding that contradicts
reports from earlier workers but did bind to a heteromultimer of labeled schistosomula surface proteins. This
is the first report of the molecular identity of a schistosome Fc receptor; moreover it demonstrates an
additional aspect of the unusual and multifunctional properties of Pmy from schistosomes and other parasitic
flatworms.
Schistosomes establish chronic infections in their hosts de-
spite the presence of specific cellular and humoral immune
responses. One of the most striking immunoevasive mecha-
nisms displayed by these parasites is the acquisition of host
products onto the tegument of the schistosome to mask its
foreign status. Host molecules adsorbed onto the surface in-
clude immunoglobulins (20, 40, 44), major histocompatibility
complex products (3, 36), b2-microglobulin (b2m) (40), com-
plement components (35, 38), a2-macroglobulin (7, 19), C3
decay-accelerating factor (14), and glycolipids in the form of A,
B, H, and Lewis blood group antigens (12).
More than 20 years ago, Schistosoma mansoni schistosomula
were shown to selectively bind the Fc but not the Fab fragment
of immunoglobulin G (IgG) (40). This was demonstrated by
the adhesion of rosetted sheep erythrocytes to transformed
schistosomula of S. mansoni in vitro and inhibition of adhesion
by free Fc fragments. IgG from rat, mouse, and rabbit also
inhibited rosette formation. Whereas most of the host mole-
cules listed above are adsorbed by schistosomula, receptors for
Fc and complement C3 have also been identified on the sur-
face of adult S. mansoni (38).
Our understanding of the molecular interactions between
schistosomes and their hosts has progressed significantly since
these early studies, a situation facilitated by the availability of
more than 15,000 schistosome expressed sequence tags depos-
ited in the public databases (15). However, despite this infor-
mation, schistosome surface receptors for host immune pro-
teins have yet to identified. Here, we describe the surface
biotinylation of live schistosomes and the subsequent purifica-
tion of labeled Fc- and b2m-binding proteins from the surface
of S. mansoni. We identify paramyosin (Pmy) as the Fc-binding
protein (Fc-Bp) and show that Pmy from the Asian schisto-
some, Schistosoma japonicum, also binds human Fc. Pmy is a
promising vaccine candidate for schistosomiasis; while it has
been shown to have an unusual immunomodulatory role by
binding C1q of the complement cascade (25), this is the first
report of schistosome Pmy binding to Fc, a finding with im-
portant implications for the use of this antigen as a vaccine target.
MATERIALS AND METHODS
Parasites. Adult S. mansoni (Puerto Rican strain; both sexes) were perfused
from BALB/c mice 7 to 10 weeks after infection with cercariae and washed
thoroughly in phosphate-buffered saline (PBS). The viability of worms was ex-
amined microscopically; intact parasites were washed three times in RPMI 1640
supplemented with penicillin (100 U ml21), streptomycin (100 mg ml21), am-
photericin b (Fungizone; 0.025 mg/ml), and 20 mM HEPES (RPMI-PSF) and
then cultured overnight in the same medium at 37°C in an atmosphere of 5%
CO2–95% air. Medium was changed the following morning, and parasites were
cultured for another 2 h, checked for viability and then surface biotinylated as
outlined below. S. japonicum (Sorsogon, Philippines) adult parasites were per-
fused from mice and washed in PBS, and soluble adult worm protein was
produced as previously described (43). S. mansoni schistosomula were obtained
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by mechanical transformation of cercariae according to published protocols (6)
and cultured overnight at 37°C in RPMI-PSF in an atmosphere of 5% CO2–95% air.
Surface biotinylation. Live adults or schistosomula of S. mansoni were surface
biotinylated using sulfo-N-hydroxysuccinimide-LC-biotin (Pierce) as previously
described (8). After removal of free biotin and washing, parasites were resus-
pended in Tris-buffered saline (TBS)–1% Triton X-100 and incubated on ice for
30 min with occasional agitation. The supernatants, hereafter referred to as
bio-ad-TX (adult worms) or bio-som-TX (schistosomula), were then removed,
centrifuged at 10,000 3 g and dialyzed overnight against 500 volumes of TBS–10
mM CaCl2. Protease inhibitors (all purchased from Sigma) were added to the
extract at the final concentrations given in parentheses: E64 (10 mM), pepstatin
A (5 mM), and PMSF (1 mM). The extract was then stored at 280°C until use.
Two different surface extracts were prepared from adult worms, the first was
from parasites that were perfused from mice and washed thoroughly in RPMI-
PSF for 5 min before surface biotinylation (bio-ad-TX-0), and the second was
from parasites that had been incubated in RPMI-PSF for 24 h as outlined above
(bio-ad-TX-24). Efficacy of the biotinylation process was monitored by precipi-
tating biotinylated proteins from extracts with streptavidin-agarose (8) and by
probing bound and unbound proteins with streptavidin-peroxidase or various
antisera as follows. Bound and unbound proteins were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
to nitrocellulose paper (NCP), and the membrane was blocked overnight in 5%
skimmed milk in PBS at 4°C. Blots were probed with either horseradish perox-
idase (HRP)-conjugated streptavidin (1 mg/ml; Sigma) or a rabbit antiserum
(1:2,000) prepared against S. japonicum recombinant Pmy (rSj-Pmy) (18) for 1 h
at room temperature (RT). Pmy has been localized to the musculature under-
lying the tegument of S. mansoni adult worms and has been shown by others not
to incorporate biotin during surface labeling (8). Furthermore, S. mansoni and S.
japonicum Pmy are 96% identitical at the amino acid level, and an antiserum
raised to rSj-Pmy in our laboratory has been shown to cross-react with S. mansoni
Pmy (42). Streptavidin blots were then washed with PBS–0.1% Tween 20 and
developed using an enhanced chemiluminescence substrate (Amersham). Immu-
noblots were washed then probed with goat anti-rabbit IgG-HRP (1:2,000; Bio-
Rad) for 1 h at RT, washed, and developed using chemiluminescence. Additional
monitoring of the biotinylation process was performed using antibodies raised to
recombinant tegumental antigen Sj22.6 (41) and recombinant aspartic protease
(localized to the gut) (2) of S. japonicum.
Coupling of ligands to Sepharose. Five milligrams of human IgG Fc (Rockland
Immunochemicals) was dialyzed overnight into coupling buffer (0.1 M NaHCO3,
0.5M NaCl, pH 8.3) and bound to 2 ml (packed volume) of cyanogen bromide-
activated Sepharose 4B (Pharmacia) according to the manufacturer’s instruc-
tions. Human b2m (500 mg; Sigma) was coupled to 500 ml of Sepharose as
outlined above.
Purification of biotinylated Fc-Bp. Bio-ad-TX (100 ml) or bio-som-TX (100 ml)
was added to Fc-Sepharose (50-ml packed volume) in 200 ml of TBS–0.1% Triton
X-100 (TBS-TX) and rotated on an orbital shaker for 2 h at RT. The reactions
were centrifuged, and the supernatant was retained as unbound protein. Sepha-
rose was washed three times with TBS-TX (1 ml per wash), and bound proteins
were eluted by resuspending the Sepharose in 100 ml of reducing SDS-PAGE
sample buffer and boiling. Alternatively, after washing, the following buffers were
tested for the ability to elute bound proteins from Fc-Sepharose under native
conditions: NaCl (0.6, 1.0, and 2.0 M), 0.1 M glycine (pH 2.5), and TBS–10 mM
EDTA. Supernatants and eluted proteins were electrophoresed on 10% poly-
acrylamide gels and transferred to NCP, nonreactive sites were blocked, and the
membranes were probed with HRP-streptavidin as described earlier. We at-
tempted to competitively inhibit binding of Pmy to Fc-Sepharose by pre-incu-
bating biotinylated extracts with either rabbit antiserum to rSj-Pmy (2.5 ml) or
soluble protein A (100 mg) for 1 h at RT before adding the extract to Fc-
sepharose.
Purification of biotinylated b2-m-binding proteins. Bio-som-TX (100 ml) was
added to b2m-Sepharose (50-ml settled bed volume) in 200 ml of TBS-TX, and
bound proteins were identified as outlined above for Fc-Bp. Bound proteins were
eluted by boiling in reducing SDS-PAGE loading dye.
Immunoprecipitations. To observe whether bio-ad-TX contained complexes
of Pmy and host IgG, 50 ml (packed volume) of protein G-Sepharose (Sigma) was
added to 100 ml of bio-ad-TX-0 and rotated at RT for 1 h. The sepharose was
then centrifuged and washed three times with TBS-TX, and bound proteins were
eluted by boiling in SDS-PAGE reducing sample buffer. Proteins were electro-
phoresed, transferred to NCP, and probed with anti-rSj-Pmy serum; this and all
subsequent steps were performed as outlined above.
Preparation of Fab fragments. Rabbit immunoglobulins were purified from
either 10 ml of anti-Pmy serum or 10 ml of normal rabbit serum by using protein
G-Sepharose. Bound immunoglobulins were eluted in 0.1 M glycine (pH 2.8),
and 0.1 M Tris was added until the solution reached pH 8.0. Immunoglobulins
were buffer exchanged into 0.1 M sodium acetate (pH 5.5) in Amicon Centricon
10 concentrators (Millipore), and Fab was cleaved from Fc domains by using
papain according to published protocols (13). Cleaved Fc regions and entire,
uncleaved immunoglobulins were removed using protein G-Sepharose. The re-
maining, unbound Fab regions were tested for recognition of Pmy by dot blot-
ting.
Microscopy. S. mansoni mechanically transformed schistosomula were fixed in
100% methanol and stored at 220°C. Worms were transferred to PBS at RT and
processed for fluorescence microscopy as follows. All fluorescent media were
processed in PBS. Schistosomula were incubated in fluorescein isothiocyanate
(FITC)-conjugated Fc (17 mg/ml) for 24 h at 4°C and rinsed in multiple changes
of PBS. Other schistosomula were incubated concurrently in the following media
for 24 h: (i) unconjugated Fc fragment (17 mg/ml, Rockland), (ii) Cy3-conjugated
rabbit anti-human Fc (17 mg/ml, Sigma), (iii) anti-Pmy serum diluted 1:200, (iv)
normal rabbit serum diluted 1:200, (v) anti-Pmy Fab fragment, and (vi) normal
rabbit Fab. After several rinses in PBS, all samples except sample (ii) were
incubated in human Fc-FITC (17 mg/ml) for 24 h at 4°C. In parallel experiments,
schistosomula were incubated in a 1:200 dilution of anti-Pmy serum for 24 h at
4°C, followed by incubation in Cy3-conjugated anti-rabbit IgG serum (Jackson
Laboratories) diluted 1:300 in PBS. All samples for fluorescence were mounted
in DABCO and examined using an Olympus BX60 fluorescence microscope.
RESULTS AND DISCUSSION
Surface biotinylation of S. mansoni. Live S. mansoni adults,
determined to be undamaged by microscopic analysis, were
subjected to surface biotinylation as previously described (8).
In their pioneering studies, Davies and Pearce (8) used Pmy as
a marker for determining the efficacy of surface labeling. They
probed biotinylated and nonbiotinylated proteins from deter-
gent extracts of adult S. mansoni (separated by precipitating
with streptavidin-agarose) with antiserum to Pmy and noted
that the protein was found only in the nonbiotinylated extract.
They concluded that their labeling was specific for exposed
surface proteins only. In a similar experiment probing labeled
and nonlabeled detergent extracts (Fig. 1A) with anti-rSj-Pmy
FIG. 1. (A) Comparison of biotinylated and nonbiotinylated sur-
face proteins of adult S. mansoni solubilized with Triton X-100 and
separated using streptavidin (strept)-agarose. Proteins were then
probed with peroxidase-labeled streptavidin (A). The left lane (un-
bound) contains proteins that were not precipitated with streptavidin-
agarose, while the right lane (bound) contains biotinylated surface
proteins that were precipitated. (B) Western blot of the extracts in
panel A probed with antiserum raised to rSj-Pmy (a-pmy), showing
that Pmy is exposed to labeling procedures on the surface of live
parasites. (C) Western blot of biotinylated and nonbiotinylated surface
proteins of S. mansoni schistosomula precipitated with streptavidin-
agarose and probed with a-pmy serum. Here and in succeeding figures,
positions of size markers are shown in kilodaltons at the left.
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serum, we found Pmy to be present in both surface and un-
derlying tissue extracts of bio-ad-TX-24 (Fig. 1B). The exact
localization of Pmy in adult schistosomes remains a matter of
debate (11, 26, 28). When probing the nonbiotinylated proteins
(i.e., those not bound by streptavidin-agarose) from bio-ad-
TX-24, we obtained reactivity with proteins with molecular
sizes of 97 kDa (Pmy) and approximately 200 kDa (Fig. 1B).
The 200-kDa antigen is most likely to be myosin, a related
muscle protein with sequence similarity to Pmy (4) but which
has not been found on the surface of adult worms (45). We
concur with this finding, as our Western blots of biotinylated
and underlying, nonbiotinylated extracts using anti-rSj-pmy se-
rum showed a band of about 200 kDa (presumed to be myosin)
only in the unlabeled fraction of bio-ad-TX-24 (i.e., subtegu-
mental tissues), while Pmy was present in both labeled and
unlabeled detergent extracts. Pmy is found in the tegument of
schistosomula, as well as in the musculature and postacetabu-
lar glands (11, 31). Antiserum to schistosome cathepsin D, an
aspartic protease found in the gut of schistosomes (2), did not
bind to surface-labeled proteins but did bind to underlying,
nonlabeled proteins (not shown), further accentuating the
specificity of the surface biotinylation procedure.
Adult schistosomes that had been cultured at 37°C overnight
were still motile after 12 h, but their teguments were sloughing
and had a patchy, blistered appearance (not shown). To test
whether Pmy was expressed only on the surface due to damage
of the tegument induced by overnight in vitro incubation
(which allowed worms to shed host IgG before surface label-
ing), we performed the same experiments with worms that had
been labeled with biotin within 1 h of removal from the host,
i.e., bio-ad-TX-0 extract. Biotinylated bio-ad-TX-0 proteins
were separated from nonbiotinylated, detergent-soluble pro-
teins by the affinity of labeled proteins for streptavidin-agarose
and then probed with anti-rSj-Pmy serum. Pmy was detected in
the biotinylated extract (Fig. 2A), indicating that it is exposed
on the tegumental surface of freshly perfused parasites as well
as those cultured in vitro after removal from the host. Mouse
IgG was detected in bio-ad-TX-0 and 224 but at a much lower
level in the latter, indicating that host IgG is shed from the
surface during overnight culturing of the parasites (Fig. 2B), a
finding supported by others using microscopic analysis (44).
S. mansoni and S. japonicum Pmy binds to Fc. When bio-ad-
TX-0, bio-ad-TX-24, and bio-som-TX were incubated with Fc-
Sepharose, a single, biotinylated band remained bound after
washing (Fig. 3A and B). The band corresponding to the Fc-Bp
was less intense in bio-ad-TX-0 than in bio-ad-TX-24, indicat-
ing that more of the protein was present in the tegument after
overnight incubation of parasites in vitro or that the majority of
host IgG had been shed by 24 h, allowing a greater quantity of
the Fc-Bp to bind to the resin. The Fc-Bp had the same mo-
lecular size as S. mansoni Pmy (97 kDa), and probing of the
bound protein with anti-rSj-pmy serum revealed its identity as
FIG. 2. Biotinylated and nonbiotinylated surface proteins of adult
S. mansoni were solubilized with Triton X-100 shortly after removal
from the host (0 h) or after 24 h culture of in vitro after removal from
the host (24 h). Surface-labeled proteins were precipitated using
streptavidin-agarose and probed with antiserum to rSj-Pmy (A) or to
murine IgG (B). The position of the light chain of IgG is shown at the
right.
FIG. 3. (A) Detection of a 97-kDa biotinylated surface protein of
adult S. mansoni that bound to human Fc-Sepharose, (seph). Extracts
were obtained from parasites that were labeled after removal from the
host (0 h) or after 24 h of culture in vitro (24 h). The blot was probed
with peroxidase-labeled streptavidin. (B) Binding of a 97-kDa biotin-
ylated protein from schistosomula to Fc. (C) Demonstration that the
bound protein from panel A (24 h) is recognized by antiserum to
rSj-Pmy (a-pmy) but not by antiserum to another tegument protein,
Sj22.6 (a-Sj 22.6). Depletion of Pmy from biotinylated surface extracts
by immunoprecipitation using anti-Pmy serum and protein G-Sepha-
rose prior to incubation of the extract with Fc-Sepharose resulted in an
absence of any Fc-BP detected using streptavidin-peroxidase (D). Pmy
eluted from Fc-Sepharose in the presence of 2 M but not 1 M NaCl, as
detected using streptavidin peroxidase (E). (F) Binding of recombi-
nant Pmy from S. mansoni (kindly provided by C. King) but not of
bovine serum albumin (BSA) control to Fc-Sepharose.
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Pmy (Fig. 3C). In addition, when Pmy was removed from
bio-ad-TX by immunoprecipitation with anti-rSj-Pmy serum,
no biotinylated proteins bound to Fc-Sepharose (Fig. 3D). Pmy
from keyhole limpet (Mollusca) also bound to human Fc (not
shown), indicating that the binding process is not restricted to
schistosome Pmy. Pmy from molluscs, cestodes, and trema-
todes has been shown to bind to collagen (22, 25, 34) and to the
collagen-like region of the complement protein C1q (25). Pmy
can be eluted from collagen using 0.6 M NaCl (22), and so we
attempted to elute Pmy from Fc-Sepharose in a similar man-
ner. Partial elution of bound Pmy was achieved with 2.0 M but
not with 1.0 M NaCl (Fig. 3E). Recombinant S. mansoni Pmy
expressed in bacteria (kindly provided by Chris King, Case
Western Reserve University, Cleveland, Ohio) also bound to
Fc-Sepharose (Fig. 3F), indicating that Pmy binds directly to
Fc and not indirectly via a complex of host and parasite proteins.
Preincubation of bio-ad-TX-24 with anti-rSj-Pmy serum be-
fore addition of the extract to Fc-Sepharose partially ablated
binding of Pmy to Fc, although bound Pmy was still detectable
(not shown). Pmy is a large molecule that adopts an alpha-
helical coiled-coil structure (16). The B-cell epitope of a pro-
tective IgE anti-Sj-Pmy monoclonal antibody has been mapped
(32), but the epitopes recognized by our polyclonal anti-rSj-
Pmy serum have yet to be determined. The antiserum we used
clearly binds to and depletes bio-ad-TX of Pmy (Fig. 3D), but
it does not appear to block all of the sites on Pmy that bind to Fc.
S. japonicum had not previously been shown to adsorb host
ligands. We therefore incubated soluble protein extracts from
adult S. japonicum with Fc-Sepharose and showed that Pmy
from this parasite also binds to IgG in a similar manner (Fig. 4).
Neither the regions of interaction between Pmy and Fc nor
the mechanisms by which they bind are understood, but the
hinge region of human Fc is somewhat promiscuous, interact-
ing with at least four different natural proteins as well as
selected small peptides that bind at a common site (10). Co-
crystallization of Fc and a 13-amino-acid peptide showed that
this common binding site is highly accessible, adaptive, and
hydrophobic, permitting binding of small peptide ligands (10)
and large proteins such as rheumatoid factor (5) and protein A
(9). We found that preincubation of Fc-Sepharose with an
excess of soluble protein A did not affect binding of Pmy to Fc
(not shown), suggesting that Pmy binds to a different region(s)
on the Fc molecule.
To observe whether Pmy-murine IgG complexes were
present on the surface of parasites when removed from the
host, mouse IgG was precipitated from bio-ad-TX-0 by using
protein G-sepharose, and bound proteins were probed with
antisera to Pmy. Pmy was detected in the precipitated complex
(Fig. 5), indicating that IgG-Pmy complexes were already
present in the extract and binding of the two proteins was not
an in vitro artifact. Probing of the precipitated complex with
anti-rSj-22.6 serum did not reveal any bands (Fig. 5). The
ability of protein G to coprecipitate IgG and Pmy provides
further evidence that Pmy binds to a unique site in the Fc
molecule, as opposed to the consensus site between the CH2
and CH3 domains.
The elution of Pmy from Fc-Sepharose by 2.0 M NaCl indi-
cates that IgG and Pmy bind due to noncovalent, ionic charge
interactions. Pmy forms an alpha-helical coiled coil, and anal-
ysis of the Caenorhabditis elegans Pmy, encoded by unc-15,
shows regular zones of positive and negative charge on the
outer surface of the helix (16). These highly charged zones are
predicted to be the areas of intermolecular interactions be-
tween Pmy molecules and between Pmy and other proteins
involved in the packing of thick muscle filaments such as my-
osin. Such charged zones might also account for the ability of
Pmy to bind to ligands such as Fc, collagen, and C1.
Torpier and colleagues showed the presence of Fc receptors
on the surface of mechanically transformed schistosomula us-
ing an erythrocyte-antierythrocyte complex (40). Probing of
fixed schistosomula with Fc-FITC also showed binding to the
parasite surface, but the strongest fluorescence was localized to
internal structures (presumed to be the vestigial penetration
glands and the nascent oral cavity) (Fig. 6B). Antiserum to
Pmy also bound to the surface of parasites but did not bind to
internal structures (Fig. 6A), suggesting that there might be
more than one Fc-Bp. To confirm these observations, we
probed schistosomula with purified Fab domains of both anti-
Pmy and normal rabbit serum and then probed parasites with
Fc-FITC. Preincubation of parasites with anti-Pmy Fab ablated
binding of Fc-FITC to the surface whereas normal rabbit Fab
did not (Fig. 6C and D). Furthermore, attempts to block Fc
binding with anti-Pmy Fab did not ablate binding to internal
glandular material yet did inhibit binding to the surface, again
FIG. 4. S. japonicum soluble extracts were incubated with Fc-
Sepharose, and bound and unbound proteins were probed with anti-
serum to rSj-Pmy (A) or antiserum to soluble adult worm protein (B).
FIG. 5. Adsorbed murine immunoglobulins and associated com-
plexes were precipitated from surface extracts of adult S. mansoni by
using protein G-Sepharose, and bound proteins were probed by West-
ern blotting with antiserum to recombinant Pmy (a-pmy) or recombi-
nant Sj22.6 (a-Sj22.6) as a control surface protein. Reactivity of the
murine immunoglobulin heavy chain with the anti-rabbit IgG second-
ary antibody is highlighted.
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suggesting the presence of distinct, internal Fc-binding pro-
teins that are unrelated to Pmy.
Antigen B is secreted by a range of cestodes, and it shares
high sequence identity with Pmy from schistosomes (23). An-
tigen B is secreted from the tegumental membrane of Taenia
solium metacestodes (24), and a homologous protein from
Taenia crassiceps binds to murine Fcg (17). Though not sur-
prising, this is nevertheless the first definitive proof that Pmy is
a receptor for Fc in schistosomes. Furthermore, a smaller,
antigen B-like coiled-coil protein from the tapeworm Moniezia
expansa binds to lipids via a hydrophobic tryptophan residue
(1). We do not know whether schistosome Pmy can bind to
lipids, but it might be an additional role for this obviously
multifunctional protein.
b2m does not bind to Pmy but does bind to other S. mansoni
surface proteins. To control for nonspecific binding of Pmy to
indiscriminate ligands or to Sepharose, we conjugated human
b2m to cyanogen bromide-activated Sepharose and repeated
the binding assays described for Fc-Sepharose using bio-som-
TX. Previously Torpier et al. (40) reported that b2m binds to
the surface of S. mansoni mechanically transformed schistoso-
mula and inhibits Fc receptor-mediated rosette formation,
prompting these authors to suggest that both Fc and b2m
bound to the same receptor on the surface of the parasite.
Furthermore, b2m associates with the intestinal Fc receptor in
neonatal rats (37). We incubated bio-som-TX with b2m-Sepha-
rose and examined the biotinylated, bound proteins. Pmy did
not bind to b2m-Sepharose, but four bands with molecular
sizes of approximately 38, 42, 110, and 200 kDa were eluted
(Fig. 7). Bound proteins were probed with anti-rSj-pmy but
were not recognized by the antibody (not shown), indicating
that b2m binds to a receptor other than Pmy on the parasite
tegument and that this receptor appears to be a heteromul-
timer. The nature of this receptor awaits elucidation.
Concluding remarks. It has long been known that schisto-
somes adsorb host Fc onto their tegument, but the molecular
mechanisms by which they achieve this process had not been
elucidated. Here we have shown that Pmy, a vaccine candidate
antigen that elicits protection against schistosomiasis in labo-
ratory and domestic animals (27, 30, 33), is an Fc-Bp. Further-
more, we have shown that host b2m does not bind to Pmy but
does bind to other proteins on the surface of schistosomula. If
schistosomes mask themselves from immune recognition by
adsorbing host proteins such as immunoglobulins, antibodies
directed at the surface receptors for these host proteins might
interfere with adsorption and thus masking. Specific antiserum
to Pmy interfered with binding of Fc to Pmy in vitro and to the
tegument of live parasites, offering a plausible explanation for
the mechanism of protection against S. mansoni infection in-
duced by anti-Pmy immunization of mice (33) and against S.
japonicum in natural reservoir hosts such as sheep (39) and
buffalo (29). Protective immunization with Pmy resulting in
decreased worm burdens in the S. mansoni murine model
appears to be primarily cell mediated and is not transferred in
serum (33). However, transfer of an IgE monoclonal antibody
against Pmy conferred partial protection in mice challenged
with S. japonicum (21), suggesting that specific antibodies
might have blocked adsorption of nonspecific Fc domains and
thus at least partially interfered with masking.
Pmy is an intriguing schistosome molecule that has received
considerable attention mainly due to its efficacy as a protective
vaccine candidate. However, investigations by others and that
reported here suggest multiple functions for this protein including
an involvement in immune evasion. This is unexpected given that
myosins and related proteins including Pmy were thought to be
primarily structural proteins located in muscle layers. By binding
to host proteins such as Fc and C1q, Pmy can potentially interfere
with immune processes such as engagement of Fc receptors on
cells and complement activation. Interactions between Pmy and
FIG. 6. Fluorescence micrograph showing binding of rabbit anti-
Pmy serum to the surface of an S. mansoni schistosomulum (A).
FITC-conjugated human Fc bound to the surface, oral cavity, and
vestigial penetration glands of schistosomula (B), while preincubation
of parasites with anti-Pmy Fab fragments ablated subsequent binding
of Fc-FITC to the surface (C); normal rabbit Fab did not interfere with
subsequent binding of Fc-FITC (D).
FIG. 7. Biotinylated b2m-binding proteins from the surface of S.
mansoni schistosomula. Bound proteins and unbound proteins were
detected using HRP-streptavidin. Bound proteins are highlighted by
arrows.
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the immune and other physiological systems need to be explored
given that schistosome Pmy is considered a prime candidate an-
tigen for a vaccine against schistosomiasis (29).
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